A detailed study on the reaction of tamoxifen for breast cancer treatment reported that high TMEM16A expression correlated with decreased survival in patients not treated with tamoxifen and with increased survival in tamoxifen-treated patients [32]. This evidence concerns the gene ANO1 and breast cancer.